Vicore Pharma Holding AB (publ) (VICO.ST)
VICO.ST Stock Price Chart
Explore Vicore Pharma Holding AB (publ) interactive price chart. Choose custom timeframes to analyze VICO.ST price movements and trends.
VICO.ST Company Profile
Discover essential business fundamentals and corporate details for Vicore Pharma Holding AB (publ) (VICO.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Dec 2015
Employees
33.00
Website
https://www.vicorepharma.comCEO
Ahmed S. Mousa
Description
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden.
VICO.ST Financial Timeline
Browse a chronological timeline of Vicore Pharma Holding AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 27 Feb 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is -kr 0.46.
Earnings released on 22 Aug 2025
Earnings released on 6 May 2025
EPS came in at -kr 0.48 falling short of the estimated -kr 0.46 by -3.46%, while revenue for the quarter reached kr 892.00K , beating expectations by +78.40%.
Earnings released on 27 Feb 2025
EPS came in at -kr 0.40 falling short of the estimated -kr 0.36 by -11.11%, while revenue for the quarter reached kr 5.10M .
Earnings released on 5 Nov 2024
EPS came in at -kr 0.54 .
Earnings released on 22 Aug 2024
EPS came in at -kr 0.50 .
Earnings released on 3 May 2024
EPS came in at kr 0.28 , while revenue for the quarter reached kr 104.24M .
Earnings released on 28 Feb 2024
EPS came in at -kr 1.00 falling short of the estimated -kr 0.59 by -69.49%.
Earnings released on 2 Nov 2023
EPS came in at -kr 0.58 surpassing the estimated -kr 0.65 by +10.77%.
Earnings released on 24 Aug 2023
EPS came in at -kr 0.85 falling short of the estimated -kr 0.73 by -16.44%.
Earnings released on 4 May 2023
EPS came in at -kr 0.81 falling short of the estimated -kr 0.78 by -3.85%.
Earnings released on 1 Mar 2023
EPS came in at -kr 0.83 falling short of the estimated -kr 0.82 by -1.07%.
Earnings released on 3 Nov 2022
EPS came in at -kr 0.95 surpassing the estimated -kr 0.97 by +2.04%.
Earnings released on 25 Aug 2022
EPS came in at -kr 0.92 surpassing the estimated -kr 1.20 by +23.51%.
Earnings released on 5 May 2022
EPS came in at -kr 1.30 falling short of the estimated -kr 1.22 by -6.65%.
Earnings released on 25 Feb 2022
EPS came in at -kr 1.12 surpassing the estimated -kr 1.51 by +25.83%.
Earnings released on 4 Nov 2021
EPS came in at -kr 1.36 surpassing the estimated -kr 1.77 by +23.16%.
Earnings released on 26 Aug 2021
EPS came in at -kr 0.98 surpassing the estimated -kr 1.76 by +44.32%.
Earnings released on 5 May 2021
EPS came in at -kr 0.76 falling short of the estimated -kr 0.58 by -31.03%.
Earnings released on 26 Feb 2021
EPS came in at -kr 0.96 falling short of the estimated -kr 0.49 by -95.92%.
Earnings released on 6 Nov 2020
EPS came in at -kr 0.65 surpassing the estimated -kr 0.89 by +26.97%.
VICO.ST Stock Performance
Access detailed VICO.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.